Intensity Tx (INTS) - Volume dana dhuwit perusahaan

Simbol resmi perusahaan Intensity Therapeutics Inc (INTS)

Intensity Therapeutics is scaling an innovative intratumoral therapy system to combat breast cancer and solid tumors. The cash balance history demonstrates liquidity, with the latest parameter standing at 0.01. Drug delivery patents ensure long-term intellectual property revenue. Furthermore, medical development remains independent of GDP, guaranteeing the company exceptional macro-resilience.

INTS - Cadangan dhuwit perusahaan intensitytherapeutics.com ing rentang 21.02.2024 - 21.11.2026

Rincian analitis perusahaan Intensity Therapeutics

Pambiji fundamental perusahaan:Intensity Therapeutics, Inc. INTS
Produk merek Intensity Therapeutics

Fundamental analysis of Intensity Therapeutics (INTS) requires a liquidity assessment, as the cash flow chart reflects the balance between financial stability and the risk of inflationary capital depreciation. For a developer of innovative intratumoral therapy, a sufficient cash reserve is critical to overcoming high barriers to entry and competing with modernized chemotherapy, ensuring research autonomy without the need for emergency high-cost debt.

Pesaing Intensity Therapeutics (INTS)

Dhuwit awis perusahaan IBRX (ImmunityBio Corp)|Gunggung dana dhuwit perusahaan IMCR|Volume dana dhuwit perusahaan JANX (Janux Therapeutics, Inc.)|Sisa dhuwit perusahaan RCUS|zymeworks.com - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Tango Therapeutics Corp|Iovance Biotherapeutics (IOVA) - Dana dhuwit perusahaan|Immatics N.V. - Sisa dhuwit perusahaan|XNCR (xencor.com) - Volume dana dhuwit perusahaan|Volume dana dhuwit perusahaan Compass Therapeutics Inc|Dana dhuwit perusahaan Replimune (REPL)|LYEL: Total volume dana dhuwit perusahaan|Innate Pharma SA - Dhuwit awis perusahaan|Pyxis Oncology, Inc. (PYXS) - Cadangan dhuwit perusahaan|Compugen - Volume dana dhuwit perusahaan|Aset likuid perusahaan IO Biotech Inc IOBT|STRO (Sutro Biopharma Inc.) - Dhuwit awis perusahaan|INKT - Aset likuid perusahaan|Dana dhuwit perusahaan werewolftx.com|Dhuwit awis perusahaan Immix Biopharma, Inc. (IMMX)|Dhuwit awis perusahaan ALXO (ALX Oncology Holdings)|Dana dhuwit perusahaan CUE (Cue Biopharma)|Volume dana dhuwit perusahaan PDSB (PDS Biotechnology Corp)|sonnetbio.com (SONN) - Cadangan dhuwit perusahaan|MAIA Biotechnology - Volume dana dhuwit perusahaan|LIMN - Volume dana dhuwit perusahaan|LVTX: Volume dana dhuwit perusahaan|NextCure - Sisa dhuwit perusahaan|LPTX (Leap Therapeutics Inc) - Volume dana dhuwit perusahaan|Dana dhuwit perusahaan SNSE|Volume dana dhuwit perusahaan TOVX|GRTS - Cadangan dhuwit perusahaan|Dana dhuwit perusahaan kinetabio.com KA|Sisa dhuwit perusahaan NEXI|turnstonebio.com - Volume dana dhuwit perusahaan|VCNX (Vaccinex, Inc) - Dhuwit awis lan setara dhuwit awis perusahaan|Harpoon Therapeutics (HARP) - Dana dhuwit perusahaan